PML-retinoic acid receptor α inhibits PML IV enhancement of PU.1-induced C/EBPε expression in myeloid differentiation

Molecular and Cellular Biology

Volumn 27, Issue 16, 2007, Pages 5819-5834

  Yoshida, Hitoshi ^a   Ichikawa, Hitoshi ^a   Tagata, Yusuke ^a   Katsumoto, Takuo ^a   Ohnishi, Kazunori ^b   Akao, Yukihiro ^c   Naoe, Tomoki ^d   Pandolfi, Pier Paolo ^e   Kitabayashi, Issay ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c GIFU INTERNATIONAL INSTITUTE OF BIOTECHNOLOGY   (Japan)

^d NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^e MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN; CCAAT ENHANCER BINDING PROTEIN EPSILON; PROMYELOCYTIC LEUKEMIA PROTEIN; PROTEIN P300; RETINOIC ACID; RETINOIC ACID RECEPTOR ALPHA; TRANSCRIPTION FACTOR PU 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BONE MARROW CELL; CELL DIFFERENTIATION; CELL MATURATION; COMPLEX FORMATION; CONTROLLED STUDY; GENETIC TRANSCRIPTION; GRANULOCYTE; GRANULOPOIESIS; HUMAN; HUMAN CELL; LEUKEMIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; STRUCTURE ACTIVITY RELATION;

ANIMALS; BASE SEQUENCE; CCAAT-ENHANCER-BINDING PROTEINS; CELL DIFFERENTIATION; E1A-ASSOCIATED P300 PROTEIN; GRANULOCYTE PRECURSOR CELLS; HELA CELLS; HUMANS; MICE; MOLECULAR SEQUENCE DATA; MYELOID CELLS; MYELOPOIESIS; NEOPLASM PROTEINS; NIH 3T3 CELLS; NUCLEAR PROTEINS; ONCOGENE PROTEINS, FUSION; PROTEIN BINDING; PROTEIN ISOFORMS; PROTO-ONCOGENE PROTEINS; STRUCTURE-ACTIVITY RELATIONSHIP; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TUMOR SUPPRESSOR PROTEINS;

MUS;

EID: 34547873122     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.02422-06     Document Type: Article

References (41)

1. Chen, H., D. Ray-Gallet, P. Zhang, C. J. Hetherington, D. A. Gonzalez, D. Zhang, F. Moreau-Gachelin, and D. G. Tenen. 1995. PU.1 (Spi-1) autoregulates its expression in myeloid cells. Oncogene 11:1549-1560.
2. Chumakov, A. M., I. Grillier, E. Chumakov, D. Chih, J. Slater, and H. P. Koeffler. 1997. Cloning of the novel human myeloid-cell-specific C/EBP-epsilon transcription factor. Mol. Cell. Biol. 17:1375-1386.
3. de The, H., C. Lavau, A. Marchio, C. Chomienne, L. Degos, and A. Dejean. 1991. The PML-RAR alpha fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR. Cell 66:675-684.
4. Duprez, E., K. Wagner, H. Koch, and D. G. Tenen. 2003. C/EBPβ: a major PML-RARA-responsive gene in retinoic acid-induced differentiation of APL cells. EMBO J. 22:5806-5816.
5. Fisher, R. C., and E. W. Scott. 1998. Role of PU.1 in hematopoiesis. Stem Cells 16:25-37.
6. Friedman, A. D. 2002. Transcriptional regulation of granulocyte and monocyte development. Oncogene 21:3377-3390.
7. Gombart, A. F., S. H. Kwok, K. Anderson, Y. Yamaguchi, B. E. Torbett, and H. P. Koeffler. 2003. Regulation of neutrophil and eosinophil secondary granule gene expression by transcription factors C/EBP epsilon and PU.1. Blood 101:3265-3273.
8. Grimwade, D., A. Biondi, M. J. Mozziconacci, A. Hagemeijer, R. Berger, M. Neat, K. Howe, N. Dastugue, J. Jansen, I. Radford-Weiss, F. Lo Coco, M. Lessard, J. M. Hernandez, E. Delabesse, D. Head, V. Liso, D. Sainty, G. Flandrin, E. Solomon, F. Birg, M. Lafage-Pochitaloff, et al. 2000. Characterization of acute promyelocytic leukemia cases lacking the classic t(15;17): results of the European Working Party. Blood 96:1297-1308.
9. Jensen, K., C. Shiels, and P. S. Freemont. 2001. PML protein isoforms and the RBCO/TRIM motif. Oncogene 20:7223-7233.
10. Kakizuka, A., W. H. Miller, Jr., K. Umesono, R. P. Warrell, Jr., S. R. Frankel, V. V. Murty, E. Dmitrovsky, and R. M. Evans. 1991. Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RAR alpha with a novel putative transcription factor, PML. Cell 66:663-674.
11. Kastner, P., and S. Chan. 2001. Function of RARalpha during the maturation of neutrophils. Oncogene 20:7178-7185.
12. Kastner, P., H. J. Lawrence, C. Waltzinger, N. B. Ghyselinck, P. Chambon, and S. Chan. 2001. Positive and negative regulation of granulopoiesis by endogenous RARalpha. Blood 97:1314-1320.
13. Klemsz, M. J., S. R. McKercher, A. Celada, C. Van Beveren, and R. A. Maki. 1990. The macrophage and B cell-specific transcription factor PU.1 is related to the ets oncogene. Cell 61:113-124.
14. Kubota, T., T. Hirama, W. Verbeek, S. Kawano, D. Y. Chih, A. M. Chumakov, H. Taguchi, and H. P. Koeffler. 2001. DNase I hypersensitivity analysis of the human CCAAT enhancer binding protein epsilon (C/EBPepsilon) gene. Leuk. Res. 25:981-995.
15. Kuwata, T., I. M. Wang, T. Tamura, R. M. Ponnamperuma, R. Levine, K. L. Holmes, H. C. Morse, L. M. De Luca, and K. Ozato. 2000. Vitamin A deficiency in mice causes a systemic expansion of myeloid cells. Blood 95:3349-3356.
16. Lee, K. H., T. Kinashi, K. Tohyama, K. Tashiro, N. Funato, K. Hama, and T. Honjo. 1991. Different stromal cell lines support lineage-selective differentiation of the multipotential bone marrow stem cell clone LyD9. J. Exp. Med. 173:1257-1266.
17. Lekstrom-Himes, J. A. 2001. The role of C/EBPε in the terminal stages of granulocyte differentiation. Stem Cells 19:125-133.
18. Matsushita, H., P. P. Scaglioni, M. Bhaumik, E. M. Rego, L. F. Cai, S. M. Majid, H. Miyachi, A. Kakizuka, W. H. Miller, Jr., and P. P. Pandolfi. 2006. In vivo analysis of the role of aberrant histone deacetylase recruitment and RAR alpha blockade in the pathogenesis of acute promyelocytic leukemia. J. Exp. Med. 203:821-828.
19. McKercher, S. R., B. E. Torbett, K. L. Anderson, G. W. Henkel, D. J. Vestal, H. Baribault, M. Klemsz, A. J. Feeney, G. E. Wu, C. J. Paige, and R. A. Maki. 1996. Targeted disruption of the PU.1 gene results in multiple hematopoietic abnormalities. EMBO J. 15:5647-5658.
20. Melnick, A., and J. D. Licht. 1999. Deconstructing a disease: RARalpha, its fusion partners, and their roles in the pathogenesis of acute promyelocytic leukemia. Blood 93:3167-3215.
21. Nguyen, L. A., P. P. Pandolfi, Y. Aikawa, Y. Tagata, M. Ohki, and I. Kitabayashi. 2005. Physical and functional link of the leukemia-associated factors AML1 and PML. Blood 105:292-300.
22. Olson, M. C., E. W. Scott, A. A. Hack, G. H. Su, D. G. Tenen, H. Singh, and M. C. Simon. 1995. PU.1 is not essential for early myeloid gene expression but is required for terminal myeloid differentiation. Immunity 3:703-714.
23. Park, D. J., A. M. Chumakov, P. T. Vuong, D. Y. Chih, A. F. Gombart, W. H. Miller, Jr., and H. P. Koeffler. 1999. CCAAT/enhancer binding protein epsilon is a potential retinoid target gene in acute promyelocytic leukemia treatment. J. Clin. Investig. 103:1399-1408.
24. Park, D. J., P. T. Vuong, S. de Vos, D. Douer, and H. P. Koeffler. 2003. Comparative analysis of genes regulated by PML/RAR alpha and PLZF/RAR alpha in response to retinoic acid using oligonucleotide arrays. Blood 102:3727-3736.
25. Piazza, F., C. Gurrieri, and P. P. Pandolfi. 2001. The theory of APL. Oncogene 20:7216-7222.
26. Rosenbauer, F., K. Wagner, J. L. Kutok, H. Iwasaki, M. M. Le Beau, Y. Okuno, K. Akashi, S. Fiering, and D. G. Tenen. 2004. Acute myeloid leukemia induced by graded reduction of a lineage-specific transcription factor, PU.1. Nat. Genet. 36:624-630.
27. Scott, E. W., M. C. Simon, J. Anastasi, and H. Singh. 1994. Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages. Science 265:1573-1577.
28. Sternsdorf, T., V. T. Phan, M. L. Maunakea, C. B. Ocampo, J. Sohal, A. Silletto, F. Galimi, M. M. Le Beau, R. M. Evans, and S. C. Kogan. 2006. Forced retinoic acid receptor alpha homodimers prime mice for APL-like leukemia. Cancer Cell 9:81-94.
29. Truong, B. T., Y. J. Lee, T. A. Lodie, D. J. Park, D. Perrotti, N. Watanabe, H. P. Koeffler, H. Nakajima, D. G. Tenen, and S. C. Kogan. 2003. CCAAT/enhancer binding proteins repress the leukemic phenotype of acute myeloid leukemia. Blood 101:1141-1148.
30. Walter, M. J., J. S. Park, R. E. Ries, S. K. Lau, M. McLellan, S. Jaeger, R. K. Wilson, E. Mardis, and T. J. Ley. 2005. Reduced PU.1 expression causes myeloid progenitor expansion and increased leukemia penetrance in mice expressing PML-RARalpha. Proc. Natl. Acad. Sci. USA 102:12513-12518.
31. Wang, X., E. Scott, C. L. Sawyers, and A. D. Friedman. 1999. C/EBPα bypasses granulocyte colony-stimulating factor signals to rapidly induce PU.1 gene expression, stimulates granulocyte differentiation and limit proliferation in 32Dcl3 myeloblasts. Blood 94:560-571.
32. Wang, Z. G., L. Delva, M. Gaboli, R. Rivi, M. Giorgio, C. Cordon-Cardo, F. Grosveld, and P. P. Pandolfi. 1998. Role of PML in cell growth and the retinoic acid pathway. Science 279:1547-1551.
33. Yamamoto, H., F. Kihara-Negishi, T. Yamada, Y. Hashimoto, and T. Oikawa. 1999. Physical and functional interactions between the transcription factor PU.1 and the coactivator CBP. Oncogene 18:1495-1501.
34. Yamanaka, R., G. D. Kim, H. S. Radomska, J. Lekstrom-Himes, L. T. Smith, P. Antonson, D. G. Tenen, and K. G. Xanthopoulos. 1997. CCAAT/enhancer binding protein epsilon is preferentially up-regulated during granulocytic differentiation and its functional versatility is determined by alternative use of promoters and differential splicing. Proc. Natl. Acad. Sci. USA 94:6462-6467.
35. Yamanaka, R., C. Barlow, J. Lekstrom-Himes, L. H. Castilla, P. P. Liu, M. Eckhaws, T. Decker, A. Wynshaw-Boris, and K. G. Xanthopoulos. 1997. Impaired granulopoiesis, myelodysplasia, and early lethality in CCAAT/enhancer binding protein epsilon-deficient mice. Proc. Natl. Acad. Sci. USA 94:13187-13192.
36. Yoshida, H., K. Kitamura, K. Tanaka, S. Omura, T. Miyazaki, T. Hachiya, R. Ohno, and T. Naoe. 1996. Accelerated degradation of PML-retinoic acid receptor alpha (PML-RARA) oncoprotein by all-trans-retinoic acid in acute promyelocytic leukemia: possible role of the proteasome pathway. Cancer Res. 56:2945-2948.
37. Zelent, A., F. Guidez, A. Melnick, S. Waxman, and J. D. Licht. 2001. Translocations of the RARalpha gene in acute promyelocytic leukemia. Oncogene 20:7186-7203.
38. Zhang, P., E. Nelson, H. S. Radomska, J. Iwasaki-Arai, K. Akashi, A. D. Friedman, and D. G. Tenen. 2002. Induction of granulocytic differentiation by 2 pathways. Blood 99:4406-4412.
39. Zhong, S., L. Delva, C. Rachez, C. Cenciarelli, D. Gandini, H. Zhang, S. Kalantry, L. P. Freedman, and P. P. Pandolfi. 1999. A RA-dependent, tumour-growth suppressive transcription complex is the target of the PML-RARalpha and T18 oncoproteins. Nat. Genet. 23:287-295.
40. Zhong, S., S. Muller, S. Ronchetti, P. Freemont, A. Dejean, and P. P. Pandolfi. 2000. Role of SUMO-1-modified PML in nuclear body formation. Blood 95:2748-2753.
41. Zhong, S., P. Salomoni, and P. P. Pandolfi. 2000. The transcriptional role of PML and the nuclear body. Nat. Cell Biol. 5:85-90.